Skip to content
2000
Volume 3, Issue 2
  • ISSN: 1573-4021
  • E-ISSN: 1875-6506

Abstract

Clinical and autopsy studies have suggested that patients with hypothyroidism have more advanced coronary atherosclerosis. The accelerated atherosclerosis has been explained by increases in low density lipoprotein cholesterol, blood pressure and newer risk factors such as homocysteine, C-reactive protein and plasminogen activator inhibitor-1 in hypothyroid state. In addition, recent studies have suggested that thyroid hormone has a direct effect on blood vessel, which may attenuate the progression of atherosclerosis. In addition to a direct relaxation of blood vessel through nongenomic effect, thyroid hormone has been reported to induce production of adrenomedullin and adenosine in vascular smooth muscle cells, which may be involved in vasodilation. Thyroid hormone also inhibits angiotensin II type1 receptor expression and signal transduction, and attenuates neointimal formation after balloon injury. These data suggest that thyroid hormone inhibits atherogenesis through direct effects on the vasculature as well as modifying risk factors.

Loading

Article metrics loading...

/content/journals/chyr/10.2174/157340207780598464
2007-05-01
2025-10-13
Loading full text...

Full text loading...

/content/journals/chyr/10.2174/157340207780598464
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test